Showing results (251-260 of 319) with videos related to
Sort By:
Pageof 32
Journal of Drugs in Dermatology : JDD|February 6, 2023
The Safety and Efficacy of Roflumilast Cream 0.15% and 0.05% in Patients With Atopic Dermatitis: Randomized, Double-Blind, Phase 2 Proof of Concept StudyMelinda Gooderham, Leon Kircik, Matthew Zirwas, et al.Journal of Drugs in Dermatology : JDD|January 22, 2015
Long-term safety of ivermectin 1% cream vs azelaic acid 15% gel in treating inflammatory lesions of rosacea: results of two 40-week controlled, investigator-blinded trialsLinda Stein Gold, Leon Kircik, Joseph Fowler, et al.Dermatology and Therapy|June 30, 2025
Efficacy and Tolerability of a New Facial 2-Mercaptonicotinoyl Glycine-Containing Depigmenting Serum Versus Hydroquinone 4% over 3-Month Treatment of Facial MelasmaThierry Passeron, Delphine Kerob, Guénaëlle Le Dantec, et al.Virology Journal|April 4, 2013
Detection and whole genome sequence analysis of an enterovirus 68 clusterAngela K Todd, Richard J Hall, Jing Wang, et al.Physical & Occupational Therapy in Pediatrics|October 18, 2022
Coaching in an Acute Pediatric Setting: A Qualitative Approach to Understanding the Perspectives of Occupational TherapistsPei Xuan Lee, Tsz Ching Sabrina Wong, Pei Yun Beatrice Ng, et al.Aesthetic Surgery Journal|January 29, 2022
Efficacy and Safety of Letibotulinumtoxin A in the Treatment of Glabellar Lines: A Randomized, Double-Blind, Multicenter, Placebo-Controlled Phase 3 StudyDaniel S Mueller, Valentina Prinz, Jeffrey Adelglass, et al.Emerging Infectious Diseases|August 23, 2022
Fetal Loss and Preterm Birth Caused by Intraamniotic Haemophilus influenzae Infection, New ZealandThomas Hills, Caitlin Sharpe, Thomas Wong, et al.Dermatitis : Contact, Atopic, Occupational, Drug|January 24, 2013
North American Contact Dermatitis Group patch test results for 2007-2008Anthony F Fransway, Kathryn A Zug, Donald V Belsito, et al.Dermatology and Therapy|July 22, 2023
Racial and Ethnic Differences in Sociodemographic, Clinical, and Treatment Characteristics Among Patients with Atopic Dermatitis in the United States and Canada: Real-World Data from the CorEvitas Atopic Dermatitis RegistryJonathan I Silverberg, Vivian Y Shi, Andrew Alexis, et al.Journal of the American Academy of Dermatology|June 1, 2019
A randomized phase 3b/4 study to evaluate concomitant use of topical ivermectin 1% cream and doxycycline 40-mg modified-release capsules, versus topical ivermectin 1% cream and placebo in the treatment of severe rosaceaMartin Schaller, Lajos Kemény, Blanka Havlickova, et al.Pageof 32